Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 6.04544385 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.04544385 |
3 | L-phenylalanine metabolic process (GO:0006558) | 5.94408287 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.94408287 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 5.43984810 |
6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.41478768 |
7 | kynurenine metabolic process (GO:0070189) | 5.26200859 |
8 | glyoxylate metabolic process (GO:0046487) | 5.22778024 |
9 | lysine metabolic process (GO:0006553) | 5.16674008 |
10 | lysine catabolic process (GO:0006554) | 5.16674008 |
11 | indole-containing compound catabolic process (GO:0042436) | 4.98168914 |
12 | indolalkylamine catabolic process (GO:0046218) | 4.98168914 |
13 | tryptophan catabolic process (GO:0006569) | 4.98168914 |
14 | alpha-linolenic acid metabolic process (GO:0036109) | 4.83948712 |
15 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.83066446 |
16 | regulation of triglyceride catabolic process (GO:0010896) | 4.74149057 |
17 | bile acid biosynthetic process (GO:0006699) | 4.69075684 |
18 | neutrophil activation involved in immune response (GO:0002283) | 4.68444896 |
19 | tryptophan metabolic process (GO:0006568) | 4.68340747 |
20 | urea cycle (GO:0000050) | 4.51355714 |
21 | urea metabolic process (GO:0019627) | 4.51355714 |
22 | high-density lipoprotein particle remodeling (GO:0034375) | 4.48326018 |
23 | 2-oxoglutarate metabolic process (GO:0006103) | 4.47599909 |
24 | amino-acid betaine metabolic process (GO:0006577) | 4.44118295 |
25 | negative regulation of fibrinolysis (GO:0051918) | 4.42422054 |
26 | cysteine metabolic process (GO:0006534) | 4.41060701 |
27 | sulfur amino acid catabolic process (GO:0000098) | 4.37092560 |
28 | cellular ketone body metabolic process (GO:0046950) | 4.36516227 |
29 | response to peptidoglycan (GO:0032494) | 4.32560627 |
30 | protein carboxylation (GO:0018214) | 4.32179362 |
31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.32179362 |
32 | fatty acid transmembrane transport (GO:1902001) | 4.30782902 |
33 | fatty acid beta-oxidation (GO:0006635) | 4.29992868 |
34 | complement activation, alternative pathway (GO:0006957) | 4.29505571 |
35 | serine family amino acid catabolic process (GO:0009071) | 4.28195456 |
36 | regulation of protein activation cascade (GO:2000257) | 4.20917538 |
37 | regulation of fibrinolysis (GO:0051917) | 4.17797747 |
38 | nitrogen cycle metabolic process (GO:0071941) | 4.16913748 |
39 | acetyl-CoA metabolic process (GO:0006084) | 4.16640935 |
40 | aspartate family amino acid catabolic process (GO:0009068) | 4.15355418 |
41 | carnitine shuttle (GO:0006853) | 4.11431995 |
42 | acylglycerol homeostasis (GO:0055090) | 4.06448054 |
43 | triglyceride homeostasis (GO:0070328) | 4.06448054 |
44 | alpha-amino acid catabolic process (GO:1901606) | 4.06239205 |
45 | negative regulation of interleukin-12 production (GO:0032695) | 4.05730636 |
46 | homocysteine metabolic process (GO:0050667) | 4.04136954 |
47 | regulation of cholesterol esterification (GO:0010872) | 4.03984649 |
48 | fatty acid oxidation (GO:0019395) | 4.03605889 |
49 | short-chain fatty acid metabolic process (GO:0046459) | 4.03545648 |
50 | bile acid metabolic process (GO:0008206) | 3.99067199 |
51 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.98646718 |
52 | plasma lipoprotein particle clearance (GO:0034381) | 3.98180948 |
53 | fatty acid catabolic process (GO:0009062) | 3.97483667 |
54 | aromatic amino acid family metabolic process (GO:0009072) | 3.96727702 |
55 | lipid oxidation (GO:0034440) | 3.96020309 |
56 | regulation of complement activation (GO:0030449) | 3.94529390 |
57 | plasma lipoprotein particle remodeling (GO:0034369) | 3.90176644 |
58 | protein-lipid complex remodeling (GO:0034368) | 3.90176644 |
59 | macromolecular complex remodeling (GO:0034367) | 3.90176644 |
60 | reverse cholesterol transport (GO:0043691) | 3.90074523 |
61 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.89175544 |
62 | phospholipid efflux (GO:0033700) | 3.86893814 |
63 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.85677134 |
64 | monocarboxylic acid catabolic process (GO:0072329) | 3.85413612 |
65 | ethanol oxidation (GO:0006069) | 3.85295032 |
66 | coenzyme catabolic process (GO:0009109) | 3.79965565 |
67 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.79675127 |
68 | carnitine metabolic process (GO:0009437) | 3.78302828 |
69 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.77934350 |
70 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.77934350 |
71 | modulation by symbiont of host immune response (GO:0052553) | 3.77934350 |
72 | positive regulation by symbiont of host defense response (GO:0052509) | 3.77934350 |
73 | modulation by symbiont of host defense response (GO:0052031) | 3.77934350 |
74 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.77934350 |
75 | cellular amino acid catabolic process (GO:0009063) | 3.77917282 |
76 | regulation of sequestering of triglyceride (GO:0010889) | 3.77577580 |
77 | phospholipid homeostasis (GO:0055091) | 3.77566415 |
78 | ketone body metabolic process (GO:1902224) | 3.76074967 |
79 | tyrosine metabolic process (GO:0006570) | 3.73809540 |
80 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.73663479 |
81 | glutamate metabolic process (GO:0006536) | 3.68453333 |
82 | positive regulation of lipid catabolic process (GO:0050996) | 3.67083433 |
83 | negative regulation of cholesterol transport (GO:0032375) | 3.66923179 |
84 | negative regulation of sterol transport (GO:0032372) | 3.66923179 |
85 | macrophage activation involved in immune response (GO:0002281) | 3.64587816 |
86 | organic acid catabolic process (GO:0016054) | 3.61039065 |
87 | carboxylic acid catabolic process (GO:0046395) | 3.61039065 |
88 | immunoglobulin mediated immune response (GO:0016064) | 3.60878507 |
89 | cellular modified amino acid catabolic process (GO:0042219) | 3.54374301 |
90 | negative regulation of cell killing (GO:0031342) | 3.52734616 |
91 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.52734616 |
92 | valine metabolic process (GO:0006573) | 3.50279434 |
93 | benzene-containing compound metabolic process (GO:0042537) | 3.48726538 |
94 | positive regulation of fatty acid oxidation (GO:0046321) | 3.48353018 |
95 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.48100727 |
96 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.48100727 |
97 | cellular glucuronidation (GO:0052695) | 3.46941942 |
98 | cholesterol efflux (GO:0033344) | 3.43350662 |
99 | indolalkylamine metabolic process (GO:0006586) | 3.43224094 |
100 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.39301279 |
101 | glycine metabolic process (GO:0006544) | 3.39271953 |
102 | regulation of fatty acid oxidation (GO:0046320) | 3.39046669 |
103 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.38569219 |
104 | branched-chain amino acid catabolic process (GO:0009083) | 3.38208893 |
105 | drug catabolic process (GO:0042737) | 3.36191244 |
106 | regulation of cholesterol homeostasis (GO:2000188) | 3.36014300 |
107 | negative regulation of lipase activity (GO:0060192) | 3.35521167 |
108 | bile acid and bile salt transport (GO:0015721) | 3.35231324 |
109 | arginine metabolic process (GO:0006525) | 3.35223033 |
110 | detection of other organism (GO:0098543) | 3.35215923 |
111 | plasma lipoprotein particle assembly (GO:0034377) | 3.34474124 |
112 | cholesterol homeostasis (GO:0042632) | 3.33129360 |
113 | cellular biogenic amine catabolic process (GO:0042402) | 3.32691875 |
114 | amine catabolic process (GO:0009310) | 3.32691875 |
115 | tricarboxylic acid cycle (GO:0006099) | 3.32689334 |
116 | sterol homeostasis (GO:0055092) | 3.27855048 |
117 | serine family amino acid metabolic process (GO:0009069) | 3.25794753 |
118 | carnitine transmembrane transport (GO:1902603) | 3.25020340 |
119 | regulation of mast cell degranulation (GO:0043304) | 3.23169747 |
120 | detection of bacterium (GO:0016045) | 3.22170557 |
121 | germinal center formation (GO:0002467) | 3.16072001 |
122 | glycosphingolipid catabolic process (GO:0046479) | 3.13292201 |
123 | granulocyte activation (GO:0036230) | 3.07974336 |
124 | oxygen transport (GO:0015671) | 3.01449280 |
125 | response to thyroid hormone (GO:0097066) | 3.00443681 |
126 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.99464517 |
127 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.98270879 |
128 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.97696615 |
129 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.93241465 |
130 | detection of external biotic stimulus (GO:0098581) | 2.92188143 |
131 | NIK/NF-kappaB signaling (GO:0038061) | 2.88314237 |
132 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.87259316 |
133 | low-density lipoprotein particle clearance (GO:0034383) | 2.86874318 |
134 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.86222478 |
135 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.84207720 |
136 | neutrophil activation (GO:0042119) | 2.82571751 |
137 | detection of molecule of bacterial origin (GO:0032490) | 2.82459219 |
138 | glycolipid catabolic process (GO:0019377) | 2.80902849 |
139 | defense response to protozoan (GO:0042832) | 2.80255683 |
140 | response to protozoan (GO:0001562) | 2.79970276 |
141 | type I interferon signaling pathway (GO:0060337) | 2.76938627 |
142 | cellular response to type I interferon (GO:0071357) | 2.76938627 |
143 | regulation of necroptotic process (GO:0060544) | 2.76502786 |
144 | regulation of gamma-delta T cell activation (GO:0046643) | 2.76399515 |
145 | myeloid dendritic cell differentiation (GO:0043011) | 2.75398294 |
146 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.75198353 |
147 | regulation of leukocyte degranulation (GO:0043300) | 2.74792758 |
148 | T-helper 1 type immune response (GO:0042088) | 2.74567468 |
149 | regulation of necrotic cell death (GO:0010939) | 2.73709370 |
150 | response to type I interferon (GO:0034340) | 2.72726582 |
151 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.70706522 |
152 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.68611353 |
153 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.68238578 |
154 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.66765883 |
155 | oligosaccharide catabolic process (GO:0009313) | 2.66605030 |
156 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.65958925 |
157 | regulation of cholesterol storage (GO:0010885) | 2.65408523 |
158 | myeloid cell activation involved in immune response (GO:0002275) | 2.63220888 |
159 | amino sugar catabolic process (GO:0046348) | 2.60567254 |
160 | creatine metabolic process (GO:0006600) | 2.60476267 |
161 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.60080321 |
162 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.59545964 |
163 | macrophage activation (GO:0042116) | 2.58765378 |
164 | B cell mediated immunity (GO:0019724) | 2.58234373 |
165 | response to host immune response (GO:0052572) | 2.57743837 |
166 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.57743837 |
167 | NADH metabolic process (GO:0006734) | 2.56168311 |
168 | gas transport (GO:0015669) | 2.55459882 |
169 | response to muramyl dipeptide (GO:0032495) | 2.55020822 |
170 | hemoglobin metabolic process (GO:0020027) | 2.53883902 |
171 | myeloid dendritic cell activation (GO:0001773) | 2.51952963 |
172 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.51341641 |
173 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.51232556 |
174 | regulation of interferon-alpha production (GO:0032647) | 2.48675443 |
175 | modulation by symbiont of host cellular process (GO:0044068) | 2.48415297 |
176 | detection of biotic stimulus (GO:0009595) | 2.48028663 |
177 | positive regulation of antigen processing and presentation (GO:0002579) | 2.48019586 |
178 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.47140077 |
179 | positive regulation of B cell differentiation (GO:0045579) | 2.46747644 |
180 | regulation of superoxide anion generation (GO:0032928) | 2.46247810 |
181 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.45358724 |
182 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.44651974 |
183 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.44501707 |
184 | ceramide catabolic process (GO:0046514) | 2.43713268 |
185 | positive regulation of mast cell activation (GO:0033005) | 2.40908331 |
186 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.40554447 |
187 | negative regulation of necroptotic process (GO:0060546) | 2.40146194 |
188 | respiratory burst (GO:0045730) | 2.39809798 |
189 | barbed-end actin filament capping (GO:0051016) | 2.39692815 |
190 | cellular extravasation (GO:0045123) | 2.39551286 |
191 | regulation of antigen processing and presentation (GO:0002577) | 2.38995343 |
192 | adenosine receptor signaling pathway (GO:0001973) | 2.38630088 |
193 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.36985845 |
194 | regulation of mast cell activation (GO:0033003) | 2.36568209 |
195 | positive regulation of cholesterol efflux (GO:0010875) | 2.36180946 |
196 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.35767577 |
197 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.35402640 |
198 | dendritic cell differentiation (GO:0097028) | 2.34936422 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.10568937 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.63287755 |
3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.26494921 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.64552144 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.12514571 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.72467470 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.86458913 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.79312551 |
9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.19899313 |
10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.84721579 |
11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.78950595 |
12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.69416989 |
13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.60339196 |
14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.50784272 |
15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.41156456 |
16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28653575 |
17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.25762133 |
18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.24112477 |
19 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.23644903 |
20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.15036411 |
21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.07277903 |
22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.1361591 |
23 | SPI1_23127762_ChIP-Seq_K562_Human | 1.98815908 |
24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.98281857 |
25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.96876130 |
26 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.92026718 |
27 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.91741795 |
28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.90412402 |
29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.86097815 |
30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.84377176 |
31 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.81134112 |
32 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.78987777 |
33 | MAF_26560356_Chip-Seq_TH1_Human | 1.78397220 |
34 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.78061321 |
35 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.76946906 |
36 | MYC_22102868_ChIP-Seq_BL_Human | 1.75384135 |
37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.73674057 |
38 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.72219194 |
39 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.70804822 |
40 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.70342000 |
41 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.70113862 |
42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.65868755 |
43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65301304 |
44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.65188053 |
45 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.61797649 |
46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60315508 |
47 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.60272556 |
48 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57937226 |
49 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.57813204 |
50 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.52975115 |
51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.52633152 |
52 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51087901 |
53 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.48519917 |
54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44631633 |
55 | MAF_26560356_Chip-Seq_TH2_Human | 1.44063804 |
56 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.42812167 |
57 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.42812167 |
58 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.41330200 |
59 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.40590224 |
60 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40417511 |
61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39670056 |
62 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.39468283 |
63 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.39413613 |
64 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37123665 |
65 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.34779426 |
66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32310193 |
67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31821591 |
68 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.31819455 |
69 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.29794837 |
70 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28388836 |
71 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.26893687 |
72 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26139468 |
73 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.22905096 |
74 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.22818462 |
75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20891003 |
76 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.20739339 |
77 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.20551368 |
78 | * P68_20966046_ChIP-Seq_HELA_Human | 1.19905678 |
79 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.19197063 |
80 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18699976 |
81 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16025892 |
82 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.15969108 |
83 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.15189354 |
84 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.12706587 |
85 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11919239 |
86 | MYB_26560356_Chip-Seq_TH2_Human | 1.09516430 |
87 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.08061540 |
88 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07824974 |
89 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07343228 |
90 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.05316161 |
91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03941150 |
92 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03785572 |
93 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.02907995 |
94 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02220177 |
95 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01894256 |
96 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01756186 |
97 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.01424693 |
98 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.00054120 |
99 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.99408256 |
100 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.99328879 |
101 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99097655 |
102 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98562336 |
103 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95307341 |
104 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.91781203 |
105 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.91331282 |
106 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.91056235 |
107 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.91034967 |
108 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90710268 |
109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90681175 |
110 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.89310297 |
111 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.87820865 |
112 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87732261 |
113 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.86318187 |
114 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.83633017 |
115 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82206276 |
116 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82164563 |
117 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80922485 |
118 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.79436056 |
119 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.79333281 |
120 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.75728079 |
121 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.74712280 |
122 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.74712280 |
123 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.73946457 |
124 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.73572757 |
125 | GATA1_19941826_ChIP-Seq_K562_Human | 0.72651648 |
126 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.72456198 |
127 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71004602 |
128 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70635422 |
129 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.70516025 |
130 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.69370118 |
131 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.69123232 |
132 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.68267549 |
133 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.67372950 |
134 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.67129071 |
135 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.65608223 |
136 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.64142678 |
137 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.63887534 |
138 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63221836 |
139 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.59104947 |
140 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.59091416 |
141 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.57824678 |
142 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.57083931 |
143 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.57042255 |
144 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.56883988 |
145 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.56783493 |
146 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.56640232 |
147 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.56503425 |
148 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.56406529 |
149 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.56248584 |
150 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.54968699 |
151 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.54862319 |
152 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.54266275 |
153 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.54211756 |
154 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.52767407 |
155 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.52365726 |
156 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.52038216 |
157 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.51388419 |
158 | CBP_21632823_ChIP-Seq_H3396_Human | 0.51360028 |
159 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.51310312 |
160 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.51189169 |
161 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.51022729 |
162 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.50705973 |
163 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.50030511 |
164 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.49541097 |
165 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.49339130 |
166 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.48500827 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.45105954 |
2 | MP0005360_urolithiasis | 6.06211296 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.12629713 |
4 | MP0005365_abnormal_bile_salt | 4.83134846 |
5 | MP0003303_peritoneal_inflammation | 4.00113027 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.93883156 |
7 | MP0003806_abnormal_nucleotide_metabolis | 3.53105580 |
8 | MP0002837_dystrophic_cardiac_calcinosis | 3.42003442 |
9 | MP0009840_abnormal_foam_cell | 3.19818468 |
10 | MP0003724_increased_susceptibility_to | 3.16992559 |
11 | MP0003436_decreased_susceptibility_to | 3.14078300 |
12 | MP0003252_abnormal_bile_duct | 3.11523768 |
13 | MP0010329_abnormal_lipoprotein_level | 3.00236673 |
14 | MP0003646_muscle_fatigue | 2.98093147 |
15 | MP0005083_abnormal_biliary_tract | 2.63477495 |
16 | MP0009785_altered_susceptibility_to | 2.55105300 |
17 | MP0002148_abnormal_hypersensitivity_rea | 2.52300562 |
18 | MP0003195_calcinosis | 2.52290522 |
19 | MP0005332_abnormal_amino_acid | 2.47992879 |
20 | MP0006082_CNS_inflammation | 2.39160355 |
21 | MP0003191_abnormal_cellular_cholesterol | 2.34950097 |
22 | MP0002419_abnormal_innate_immunity | 2.33854357 |
23 | MP0001835_abnormal_antigen_presentation | 2.31467840 |
24 | MP0005025_abnormal_response_to | 2.24392474 |
25 | MP0005397_hematopoietic_system_phenotyp | 2.20376210 |
26 | MP0001545_abnormal_hematopoietic_system | 2.20376210 |
27 | MP0005464_abnormal_platelet_physiology | 2.18990987 |
28 | MP0004130_abnormal_muscle_cell | 2.15618149 |
29 | MP0000751_myopathy | 2.11595985 |
30 | MP0005000_abnormal_immune_tolerance | 2.08069844 |
31 | MP0009278_abnormal_bone_marrow | 2.08018120 |
32 | MP0001666_abnormal_nutrient_absorption | 2.06421130 |
33 | MP0004084_abnormal_cardiac_muscle | 2.06343481 |
34 | MP0005387_immune_system_phenotype | 2.05777887 |
35 | MP0001790_abnormal_immune_system | 2.05777887 |
36 | MP0002118_abnormal_lipid_homeostasis | 1.98391661 |
37 | MP0004036_abnormal_muscle_relaxation | 1.93513879 |
38 | MP0003300_gastrointestinal_ulcer | 1.93360165 |
39 | MP0000609_abnormal_liver_physiology | 1.86105829 |
40 | MP0003075_altered_response_to | 1.85888259 |
41 | MP0005330_cardiomyopathy | 1.83617274 |
42 | MP0005319_abnormal_enzyme/_coenzyme | 1.79352712 |
43 | MP0000749_muscle_degeneration | 1.76836506 |
44 | MP0003172_abnormal_lysosome_physiology | 1.74839663 |
45 | MP0005670_abnormal_white_adipose | 1.72632238 |
46 | MP0001533_abnormal_skeleton_physiology | 1.72236466 |
47 | MP0000685_abnormal_immune_system | 1.71563952 |
48 | MP0005671_abnormal_response_to | 1.69878292 |
49 | MP0002723_abnormal_immune_serum | 1.68586181 |
50 | MP0002452_abnormal_antigen_presenting | 1.66622998 |
51 | MP0004215_abnormal_myocardial_fiber | 1.65406982 |
52 | MP0002138_abnormal_hepatobiliary_system | 1.62443851 |
53 | MP0006036_abnormal_mitochondrial_physio | 1.62375997 |
54 | MP0001800_abnormal_humoral_immune | 1.58326910 |
55 | MP0005451_abnormal_body_composition | 1.58077275 |
56 | MP0004019_abnormal_vitamin_homeostasis | 1.56919600 |
57 | MP0008260_abnormal_autophagy | 1.55849648 |
58 | MP0004947_skin_inflammation | 1.53658236 |
59 | MP0010155_abnormal_intestine_physiology | 1.53056714 |
60 | MP0002420_abnormal_adaptive_immunity | 1.52748382 |
61 | MP0001819_abnormal_immune_cell | 1.52411645 |
62 | MP0003705_abnormal_hypodermis_morpholog | 1.49912305 |
63 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.48797493 |
64 | MP0001845_abnormal_inflammatory_respons | 1.45138025 |
65 | MP0008004_abnormal_stomach_pH | 1.44316604 |
66 | MP0004087_abnormal_muscle_fiber | 1.42041682 |
67 | MP0002405_respiratory_system_inflammati | 1.38071261 |
68 | MP0005666_abnormal_adipose_tissue | 1.36775234 |
69 | MP0002269_muscular_atrophy | 1.35352612 |
70 | MP0009333_abnormal_splenocyte_physiolog | 1.33178387 |
71 | MP0005166_decreased_susceptibility_to | 1.31542493 |
72 | MP0002998_abnormal_bone_remodeling | 1.27601330 |
73 | MP0008775_abnormal_heart_ventricle | 1.26969787 |
74 | MP0010368_abnormal_lymphatic_system | 1.25399127 |
75 | MP0002132_abnormal_respiratory_system | 1.25236199 |
76 | MP0002972_abnormal_cardiac_muscle | 1.23712679 |
77 | MP0000858_altered_metastatic_potential | 1.23476107 |
78 | MP0009643_abnormal_urine_homeostasis | 1.22608697 |
79 | MP0005620_abnormal_muscle_contractility | 1.20827201 |
80 | MP0002971_abnormal_brown_adipose | 1.20398091 |
81 | MP0005385_cardiovascular_system_phenoty | 1.19340493 |
82 | MP0001544_abnormal_cardiovascular_syste | 1.19340493 |
83 | MP0003656_abnormal_erythrocyte_physiolo | 1.17854518 |
84 | MP0003453_abnormal_keratinocyte_physiol | 1.17660468 |
85 | MP0001764_abnormal_homeostasis | 1.16628772 |
86 | MP0003868_abnormal_feces_composition | 1.12983462 |
87 | MP0002398_abnormal_bone_marrow | 1.11239424 |
88 | MP0010630_abnormal_cardiac_muscle | 1.11066672 |
89 | MP0000716_abnormal_immune_system | 1.10389975 |
90 | MP0000747_muscle_weakness | 1.09968778 |
91 | MP0003186_abnormal_redox_activity | 1.07487603 |
92 | MP0000465_gastrointestinal_hemorrhage | 1.06007765 |
93 | MP0006138_congestive_heart_failure | 1.05930930 |
94 | MP0002106_abnormal_muscle_physiology | 1.01088348 |
95 | MP0000750_abnormal_muscle_regeneration | 1.00919001 |
96 | MP0009697_abnormal_copulation | 1.00499751 |
97 | MP0006035_abnormal_mitochondrial_morpho | 0.99025995 |
98 | MP0000689_abnormal_spleen_morphology | 0.98149413 |
99 | MP0002429_abnormal_blood_cell | 0.98124900 |
100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.98054256 |
101 | MP0005310_abnormal_salivary_gland | 0.97187846 |
102 | MP0000598_abnormal_liver_morphology | 0.95000249 |
103 | MP0002078_abnormal_glucose_homeostasis | 0.94600405 |
104 | MP0002332_abnormal_exercise_endurance | 0.93885801 |
105 | MP0003448_altered_tumor_morphology | 0.93692022 |
106 | MP0003137_abnormal_impulse_conducting | 0.93612598 |
107 | MP0005266_abnormal_metabolism | 0.93480361 |
108 | MP0002722_abnormal_immune_system | 0.93428935 |
109 | MP0003011_delayed_dark_adaptation | 0.89740471 |
110 | MP0009763_increased_sensitivity_to | 0.87505648 |
111 | MP0009764_decreased_sensitivity_to | 0.87260496 |
112 | MP0005535_abnormal_body_temperature | 0.86341757 |
113 | MP0004185_abnormal_adipocyte_glucose | 0.85835015 |
114 | MP0005334_abnormal_fat_pad | 0.84568699 |
115 | MP0008874_decreased_physiological_sensi | 0.83500122 |
116 | MP0000759_abnormal_skeletal_muscle | 0.83487748 |
117 | MP0000604_amyloidosis | 0.82548345 |
118 | MP0001663_abnormal_digestive_system | 0.82081799 |
119 | MP0005164_abnormal_response_to | 0.79379379 |
120 | MP0009642_abnormal_blood_homeostasis | 0.78869325 |
121 | MP0005369_muscle_phenotype | 0.78559130 |
122 | MP0001851_eye_inflammation | 0.78401304 |
123 | MP0004484_altered_response_of | 0.77966032 |
124 | MP0008469_abnormal_protein_level | 0.77405343 |
125 | MP0004145_abnormal_muscle_electrophysio | 0.76615319 |
126 | MP0005375_adipose_tissue_phenotype | 0.74819928 |
127 | MP0005636_abnormal_mineral_homeostasis | 0.74765401 |
128 | MP0005376_homeostasis/metabolism_phenot | 0.73603742 |
129 | MP0003879_abnormal_hair_cell | 0.73333767 |
130 | MP0005647_abnormal_sex_gland | 0.72200234 |
131 | MP0000230_abnormal_systemic_arterial | 0.70003415 |
132 | MP0004085_abnormal_heartbeat | 0.67944802 |
133 | MP0000343_altered_response_to | 0.66051423 |
134 | MP0004510_myositis | 0.62902432 |
135 | MP0004043_abnormal_pH_regulation | 0.59936041 |
136 | MP0005165_increased_susceptibility_to | 0.59292885 |
137 | MP0001756_abnormal_urination | 0.57470960 |
138 | MP0005448_abnormal_energy_balance | 0.57423628 |
139 | MP0005167_abnormal_blood-brain_barrier | 0.56711075 |
140 | MP0009115_abnormal_fat_cell | 0.55310450 |
141 | MP0003828_pulmonary_edema | 0.54190508 |
142 | MP0005084_abnormal_gallbladder_morpholo | 0.52510148 |
143 | MP0003690_abnormal_glial_cell | 0.51303413 |
144 | MP0002127_abnormal_cardiovascular_syste | 0.51041728 |
145 | MP0003329_amyloid_beta_deposits | 0.50220021 |
146 | MP0002254_reproductive_system_inflammat | 0.49358678 |
147 | MP0000249_abnormal_blood_vessel | 0.47327273 |
148 | MP0004147_increased_porphyrin_level | 0.46858391 |
149 | MP0001853_heart_inflammation | 0.45863606 |
150 | MP0001661_extended_life_span | 0.45762124 |
151 | MP0005058_abnormal_lysosome_morphology | 0.45223416 |
152 | MP0002128_abnormal_blood_circulation | 0.45100480 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 5.40889875 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.25456816 |
3 | Intrahepatic cholestasis (HP:0001406) | 5.13679532 |
4 | Xanthomatosis (HP:0000991) | 4.98635483 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.69400061 |
6 | Abnormality of glycolipid metabolism (HP:0010969) | 4.60180913 |
7 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.60180913 |
8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.60180913 |
9 | Hypobetalipoproteinemia (HP:0003563) | 4.42258386 |
10 | Hyperlipoproteinemia (HP:0010980) | 4.39927545 |
11 | Hyperammonemia (HP:0001987) | 4.35864538 |
12 | Ketosis (HP:0001946) | 4.33369963 |
13 | Hypoglycemic coma (HP:0001325) | 4.33161755 |
14 | Prolonged partial thromboplastin time (HP:0003645) | 4.32833539 |
15 | Eczematoid dermatitis (HP:0000976) | 4.10580984 |
16 | Abnormality of macrophages (HP:0004311) | 4.09632193 |
17 | Hyperglycinuria (HP:0003108) | 4.01901206 |
18 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.96117600 |
19 | Hypoalphalipoproteinemia (HP:0003233) | 3.89936005 |
20 | Hypolipoproteinemia (HP:0010981) | 3.87639672 |
21 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.86389171 |
22 | Complement deficiency (HP:0004431) | 3.83499830 |
23 | Ketoacidosis (HP:0001993) | 3.78980067 |
24 | Myoglobinuria (HP:0002913) | 3.78127647 |
25 | Recurrent abscess formation (HP:0002722) | 3.76181777 |
26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.75276806 |
27 | Abnormality of glycine metabolism (HP:0010895) | 3.75276806 |
28 | Hyperglycinemia (HP:0002154) | 3.66732001 |
29 | Recurrent bacterial skin infections (HP:0005406) | 3.63726741 |
30 | Exercise-induced myalgia (HP:0003738) | 3.59626035 |
31 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.55584406 |
32 | Sudden death (HP:0001699) | 3.46158303 |
33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.45703845 |
34 | Petechiae (HP:0000967) | 3.45599365 |
35 | Epidermoid cyst (HP:0200040) | 3.42975360 |
36 | Myositis (HP:0100614) | 3.42318398 |
37 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.38730009 |
38 | Joint hemorrhage (HP:0005261) | 3.36198244 |
39 | Exercise-induced muscle cramps (HP:0003710) | 3.35931021 |
40 | Orchitis (HP:0100796) | 3.34026062 |
41 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.30851481 |
42 | Dicarboxylic aciduria (HP:0003215) | 3.30851481 |
43 | Increased serum ferritin (HP:0003281) | 3.26493700 |
44 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.21555642 |
45 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.20487654 |
46 | Polycythemia (HP:0001901) | 3.17343683 |
47 | Rhabdomyolysis (HP:0003201) | 3.09910232 |
48 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.08997153 |
49 | Increased cerebral lipofuscin (HP:0011813) | 3.07574649 |
50 | Muscle fiber inclusion bodies (HP:0100299) | 3.07231548 |
51 | Abnormality of the common coagulation pathway (HP:0010990) | 3.04607218 |
52 | Abnormality of methionine metabolism (HP:0010901) | 3.02691243 |
53 | Stomatitis (HP:0010280) | 3.02581837 |
54 | Prolonged bleeding time (HP:0003010) | 2.99909612 |
55 | Purpura (HP:0000979) | 2.99348782 |
56 | Nemaline bodies (HP:0003798) | 2.97413644 |
57 | Ventricular tachycardia (HP:0004756) | 2.95879134 |
58 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.95712202 |
59 | Calf muscle hypertrophy (HP:0008981) | 2.94772332 |
60 | Optic neuritis (HP:0100653) | 2.91963533 |
61 | Retrobulbar optic neuritis (HP:0100654) | 2.91963533 |
62 | Metabolic acidosis (HP:0001942) | 2.91616678 |
63 | Abnormality of iron homeostasis (HP:0011031) | 2.90645063 |
64 | Cerebral edema (HP:0002181) | 2.90198561 |
65 | Obstructive lung disease (HP:0006536) | 2.88668258 |
66 | Chronic obstructive pulmonary disease (HP:0006510) | 2.88668258 |
67 | Dysostosis multiplex (HP:0000943) | 2.86382375 |
68 | Loss of speech (HP:0002371) | 2.86059360 |
69 | Hypercholesterolemia (HP:0003124) | 2.84198600 |
70 | Right ventricular cardiomyopathy (HP:0011663) | 2.82634577 |
71 | Vacuolated lymphocytes (HP:0001922) | 2.82094227 |
72 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.79077309 |
73 | Hypochromic microcytic anemia (HP:0004840) | 2.78834376 |
74 | Fat malabsorption (HP:0002630) | 2.78253744 |
75 | Abnormality of complement system (HP:0005339) | 2.76947729 |
76 | Abnormality of serum amino acid levels (HP:0003112) | 2.72343990 |
77 | Gout (HP:0001997) | 2.72236390 |
78 | Muscle fiber splitting (HP:0003555) | 2.71741071 |
79 | Hyporeflexia of lower limbs (HP:0002600) | 2.69263492 |
80 | Skin nodule (HP:0200036) | 2.68369505 |
81 | Abnormality of the intrinsic pathway (HP:0010989) | 2.65699294 |
82 | Lethargy (HP:0001254) | 2.64606849 |
83 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.63324789 |
84 | Disinhibition (HP:0000734) | 2.62691832 |
85 | Myopathic facies (HP:0002058) | 2.62098400 |
86 | Cholelithiasis (HP:0001081) | 2.61546550 |
87 | Abnormality of purine metabolism (HP:0004352) | 2.61381451 |
88 | Mediastinal lymphadenopathy (HP:0100721) | 2.57730398 |
89 | Generalized aminoaciduria (HP:0002909) | 2.57689261 |
90 | Hyperbilirubinemia (HP:0002904) | 2.56646861 |
91 | Distal lower limb muscle weakness (HP:0009053) | 2.53487056 |
92 | Axonal loss (HP:0003447) | 2.53333295 |
93 | Abnormality of nucleobase metabolism (HP:0010932) | 2.53175276 |
94 | Abnormal gallbladder morphology (HP:0012437) | 2.52387659 |
95 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.51363985 |
96 | Epistaxis (HP:0000421) | 2.50541276 |
97 | Palpitations (HP:0001962) | 2.50495358 |
98 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.48764787 |
99 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.48702116 |
100 | Amyloidosis (HP:0011034) | 2.45908939 |
101 | Hepatosplenomegaly (HP:0001433) | 2.45673470 |
102 | Asymmetric septal hypertrophy (HP:0001670) | 2.45330161 |
103 | Spontaneous hematomas (HP:0007420) | 2.44152817 |
104 | Myocardial infarction (HP:0001658) | 2.41994623 |
105 | Lipoatrophy (HP:0100578) | 2.38034128 |
106 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.36762925 |
107 | Delayed CNS myelination (HP:0002188) | 2.36119870 |
108 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.35060817 |
109 | Paralysis (HP:0003470) | 2.34109460 |
110 | Hepatic necrosis (HP:0002605) | 2.33825890 |
111 | Microcytic anemia (HP:0001935) | 2.33533641 |
112 | Atrioventricular block (HP:0001678) | 2.33211645 |
113 | Gastrointestinal infarctions (HP:0005244) | 2.33113777 |
114 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.32607181 |
115 | Increased connective tissue (HP:0009025) | 2.32427974 |
116 | Conjugated hyperbilirubinemia (HP:0002908) | 2.31019206 |
117 | Type 1 muscle fiber predominance (HP:0003803) | 2.28211020 |
118 | Vomiting (HP:0002013) | 2.25785763 |
119 | Reticulocytosis (HP:0001923) | 2.25186132 |
120 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.24009376 |
121 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.24009376 |
122 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.24009376 |
123 | Poikilocytosis (HP:0004447) | 2.22629392 |
124 | Hypochromic anemia (HP:0001931) | 2.20129464 |
125 | Late onset (HP:0003584) | 2.19614886 |
126 | Glomerulonephritis (HP:0000099) | 2.19310510 |
127 | Keratoconjunctivitis sicca (HP:0001097) | 2.19084082 |
128 | Urticaria (HP:0001025) | 2.18193165 |
129 | Dilated cardiomyopathy (HP:0001644) | 2.18045026 |
130 | Hepatocellular carcinoma (HP:0001402) | 2.17417852 |
131 | Nausea (HP:0002018) | 2.17291187 |
132 | Abnormality of the calf musculature (HP:0001430) | 2.17108407 |
133 | Systemic lupus erythematosus (HP:0002725) | 2.16579850 |
134 | Hypoglycemic seizures (HP:0002173) | 2.16293106 |
135 | Atrial fibrillation (HP:0005110) | 2.14663874 |
136 | Gingivitis (HP:0000230) | 2.14650945 |
137 | Syncope (HP:0001279) | 2.13802725 |
138 | Hypertensive crisis (HP:0100735) | 2.13607672 |
139 | Autoimmune thrombocytopenia (HP:0001973) | 2.10564808 |
140 | Mutism (HP:0002300) | 2.10045187 |
141 | Increased muscle lipid content (HP:0009058) | 2.09742440 |
142 | Cellulitis (HP:0100658) | 2.09608817 |
143 | Recurrent skin infections (HP:0001581) | 2.09192925 |
144 | Hypertriglyceridemia (HP:0002155) | 2.08722527 |
145 | Hyperglycemia (HP:0003074) | 2.08518556 |
146 | EMG: myopathic abnormalities (HP:0003458) | 2.08211990 |
147 | Proximal tubulopathy (HP:0000114) | 2.07934845 |
148 | Gingival bleeding (HP:0000225) | 2.06979127 |
149 | Heart block (HP:0012722) | 2.06350224 |
150 | Vascular calcification (HP:0004934) | 2.05827214 |
151 | Hyperuricemia (HP:0002149) | 2.03716022 |
152 | Increased purine levels (HP:0004368) | 2.03716022 |
153 | Spontaneous abortion (HP:0005268) | 2.02676351 |
154 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.02040148 |
155 | Arterial thrombosis (HP:0004420) | 2.01754595 |
156 | Recurrent fungal infections (HP:0002841) | 2.01349832 |
157 | Impaired platelet aggregation (HP:0003540) | 2.01293416 |
158 | Abnormal platelet function (HP:0011869) | 2.01293416 |
159 | Muscle stiffness (HP:0003552) | 2.00155127 |
160 | Steatorrhea (HP:0002570) | 1.99835575 |
161 | Neonatal onset (HP:0003623) | 1.99378206 |
162 | Chest pain (HP:0100749) | 1.98419051 |
163 | Esophageal varix (HP:0002040) | 1.98351386 |
164 | Meningitis (HP:0001287) | 1.98166800 |
165 | Abnormal gallbladder physiology (HP:0012438) | 1.96877376 |
166 | Cholecystitis (HP:0001082) | 1.96877376 |
167 | Ragged-red muscle fibers (HP:0003200) | 1.96212202 |
168 | Bulbar palsy (HP:0001283) | 1.95975679 |
169 | Episodic fever (HP:0001954) | 1.95904287 |
170 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.95680588 |
171 | Mucopolysacchariduria (HP:0008155) | 1.95680588 |
172 | Difficulty running (HP:0009046) | 1.94887662 |
173 | Primary atrial arrhythmia (HP:0001692) | 1.94870876 |
174 | Vasculitis (HP:0002633) | 1.94151078 |
175 | Acute encephalopathy (HP:0006846) | 1.93020999 |
176 | Abnormal atrioventricular conduction (HP:0005150) | 1.92952827 |
177 | Hydroxyprolinuria (HP:0003080) | 1.91760387 |
178 | Abnormality of proline metabolism (HP:0010907) | 1.91760387 |
179 | Encephalitis (HP:0002383) | 1.91666936 |
180 | Keratoconjunctivitis (HP:0001096) | 1.91293319 |
181 | Increased IgE level (HP:0003212) | 1.91169341 |
182 | Nuclear cataract (HP:0100018) | 1.90951739 |
183 | Neurofibrillary tangles (HP:0002185) | 1.86698284 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 5.51057559 |
2 | TTN | 4.05034389 |
3 | TRIB3 | 3.35944559 |
4 | RIPK4 | 3.34901446 |
5 | PKN2 | 3.21049650 |
6 | OBSCN | 3.17798715 |
7 | SIK1 | 2.80522497 |
8 | ERN1 | 2.61568231 |
9 | PRPF4B | 2.59094986 |
10 | PHKG1 | 2.58875338 |
11 | PHKG2 | 2.58875338 |
12 | FGFR4 | 2.56033998 |
13 | PDK3 | 2.44988206 |
14 | PDK4 | 2.44988206 |
15 | NME2 | 2.42913945 |
16 | BLK | 2.26894212 |
17 | TAOK1 | 2.24384538 |
18 | PINK1 | 2.18042558 |
19 | MAP4K1 | 2.13315613 |
20 | INSRR | 2.10242888 |
21 | MYLK | 1.91273355 |
22 | LMTK2 | 1.89160371 |
23 | TIE1 | 1.86854040 |
24 | IRAK4 | 1.81131612 |
25 | MAP2K3 | 1.75968301 |
26 | MAP3K1 | 1.75700634 |
27 | ZAP70 | 1.63337231 |
28 | PDK2 | 1.52820411 |
29 | MAP3K7 | 1.49879358 |
30 | FLT3 | 1.48333361 |
31 | PIK3CA | 1.48123499 |
32 | PIK3CG | 1.43207067 |
33 | FGR | 1.36976221 |
34 | MATK | 1.36895552 |
35 | NEK1 | 1.36075029 |
36 | MAP2K4 | 1.36061599 |
37 | IKBKE | 1.33536239 |
38 | NEK9 | 1.32332556 |
39 | IKBKB | 1.32268165 |
40 | JAK3 | 1.31996228 |
41 | PRKAA2 | 1.30357470 |
42 | FES | 1.27382057 |
43 | PTK6 | 1.26674320 |
44 | MST1R | 1.25864386 |
45 | TNK2 | 1.24082698 |
46 | RIPK1 | 1.21023935 |
47 | TESK2 | 1.19352981 |
48 | PIM2 | 1.17543401 |
49 | GRK6 | 1.17540091 |
50 | TAOK3 | 1.16852880 |
51 | SYK | 1.16798137 |
52 | MAPK12 | 1.15702445 |
53 | DMPK | 1.14904683 |
54 | MAP3K13 | 1.13943215 |
55 | KDR | 1.12291697 |
56 | MAPK11 | 1.11700304 |
57 | EPHB1 | 1.07420360 |
58 | ERBB4 | 1.07226126 |
59 | TGFBR2 | 1.06475736 |
60 | TYK2 | 1.06393481 |
61 | TBK1 | 1.06047109 |
62 | MAP3K3 | 1.03172908 |
63 | LATS1 | 1.01397248 |
64 | BTK | 1.00998382 |
65 | MOS | 0.99190289 |
66 | PRKAA1 | 0.98635844 |
67 | BMX | 0.95807509 |
68 | MUSK | 0.94806330 |
69 | HCK | 0.91895720 |
70 | CDC42BPA | 0.91627348 |
71 | LYN | 0.88010874 |
72 | STK38L | 0.87448016 |
73 | PAK3 | 0.85363462 |
74 | DDR2 | 0.85234311 |
75 | STK24 | 0.84832636 |
76 | ABL2 | 0.84185718 |
77 | MARK3 | 0.83693000 |
78 | MAP3K5 | 0.82980574 |
79 | CAMK1D | 0.82020975 |
80 | JAK2 | 0.80656442 |
81 | MAP2K6 | 0.79803444 |
82 | KSR2 | 0.78772181 |
83 | PRKD1 | 0.78346952 |
84 | TXK | 0.75285364 |
85 | CSF1R | 0.73992131 |
86 | JAK1 | 0.73773481 |
87 | PDPK1 | 0.66909516 |
88 | PRKACG | 0.65506397 |
89 | MAP3K8 | 0.65055309 |
90 | DAPK2 | 0.64854900 |
91 | MAP3K11 | 0.63234423 |
92 | TESK1 | 0.61203498 |
93 | SIK3 | 0.60170140 |
94 | SCYL2 | 0.60041712 |
95 | LCK | 0.58901327 |
96 | MARK2 | 0.58459407 |
97 | CAMK2G | 0.58181001 |
98 | RPS6KC1 | 0.57686818 |
99 | RPS6KL1 | 0.57686818 |
100 | IRAK3 | 0.57608056 |
101 | GRK7 | 0.56985325 |
102 | BMPR2 | 0.56955295 |
103 | IRAK2 | 0.56263659 |
104 | TAOK2 | 0.56245674 |
105 | PIM1 | 0.55484255 |
106 | CAMK4 | 0.54885098 |
107 | WNK4 | 0.54301828 |
108 | MAPKAPK3 | 0.54218622 |
109 | PRKG2 | 0.53533531 |
110 | MAPK4 | 0.53436722 |
111 | PKN1 | 0.53107887 |
112 | SGK3 | 0.52503477 |
113 | PDGFRA | 0.51538978 |
114 | CAMK2D | 0.50470304 |
115 | KIT | 0.47664039 |
116 | EPHA3 | 0.47408766 |
117 | SMG1 | 0.43982175 |
118 | PDK1 | 0.43497282 |
119 | MAP3K10 | 0.43214756 |
120 | RPS6KA6 | 0.43022718 |
121 | ROCK1 | 0.42066548 |
122 | HIPK2 | 0.41754994 |
123 | STK10 | 0.41511627 |
124 | TRPM7 | 0.41305119 |
125 | ARAF | 0.41253013 |
126 | MET | 0.40801441 |
127 | EIF2AK1 | 0.40598589 |
128 | PRKD2 | 0.39897985 |
129 | CAMK1G | 0.39058852 |
130 | MAP2K1 | 0.39025043 |
131 | STK4 | 0.38961797 |
132 | ACVR1B | 0.38881515 |
133 | FGFR3 | 0.37871139 |
134 | CLK1 | 0.37262160 |
135 | MAP3K14 | 0.36977598 |
136 | RET | 0.36321888 |
137 | DAPK3 | 0.36149857 |
138 | ICK | 0.35914072 |
139 | DYRK1B | 0.35555502 |
140 | GSK3A | 0.35322046 |
141 | FRK | 0.33846910 |
142 | CSK | 0.33730899 |
143 | ILK | 0.33229302 |
144 | STK38 | 0.33088215 |
145 | PRKACB | 0.32083329 |
146 | PRKCZ | 0.31910798 |
147 | MAP3K6 | 0.31563354 |
148 | MTOR | 0.31121608 |
149 | MAPK7 | 0.30192310 |
150 | LRRK2 | 0.29161970 |
151 | PRKACA | 0.28724111 |
152 | FGFR2 | 0.28368904 |
153 | PRKCQ | 0.26256731 |
154 | ERBB2 | 0.26150554 |
155 | AKT2 | 0.24193514 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.84788479 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.67790970 |
3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.19417027 |
4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.11043960 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.88708028 |
6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.85725161 |
7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.82513416 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.74898326 |
9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.74489590 |
10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.72767392 |
11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.71976799 |
12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.68305554 |
13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.57889786 |
14 | Leishmaniasis_Homo sapiens_hsa05140 | 2.57395383 |
15 | Malaria_Homo sapiens_hsa05144 | 2.44510866 |
16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.37432250 |
17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.29169347 |
18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.28838507 |
19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.28444675 |
20 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.26288549 |
21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.21632733 |
22 | Lysosome_Homo sapiens_hsa04142 | 2.14390226 |
23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.14139647 |
24 | Peroxisome_Homo sapiens_hsa04146 | 2.04697382 |
25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.03426168 |
26 | Allograft rejection_Homo sapiens_hsa05330 | 2.00906107 |
27 | Tuberculosis_Homo sapiens_hsa05152 | 1.92721394 |
28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.92001615 |
29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.77794026 |
30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.76568672 |
31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.76543768 |
32 | Carbon metabolism_Homo sapiens_hsa01200 | 1.75316689 |
33 | Asthma_Homo sapiens_hsa05310 | 1.72301680 |
34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71842349 |
35 | Pertussis_Homo sapiens_hsa05133 | 1.71758511 |
36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.69903342 |
37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.69452101 |
38 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.62235674 |
39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.61496239 |
40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.57631477 |
41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.56439691 |
42 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.55730751 |
43 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.55207663 |
44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.55088091 |
45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.54683090 |
46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.54444399 |
47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.52624544 |
48 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.52161523 |
49 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.51690873 |
50 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.51567745 |
51 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.47779539 |
52 | Histidine metabolism_Homo sapiens_hsa00340 | 1.46024950 |
53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.45599387 |
54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.43472141 |
55 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.42730411 |
56 | Legionellosis_Homo sapiens_hsa05134 | 1.42546859 |
57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.41485644 |
58 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39256035 |
59 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.38524594 |
60 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.37799175 |
61 | Bile secretion_Homo sapiens_hsa04976 | 1.37596476 |
62 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.34775597 |
63 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.29814424 |
64 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.28844769 |
65 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.28615946 |
66 | Influenza A_Homo sapiens_hsa05164 | 1.28273379 |
67 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.28027805 |
68 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27556404 |
69 | Retinol metabolism_Homo sapiens_hsa00830 | 1.27222619 |
70 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.26657367 |
71 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.22349295 |
72 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.21583091 |
73 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19678945 |
74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.14708527 |
75 | * Salmonella infection_Homo sapiens_hsa05132 | 1.13761545 |
76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.12912138 |
77 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12603658 |
78 | * Phagosome_Homo sapiens_hsa04145 | 1.12351311 |
79 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.11492083 |
80 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.06086966 |
81 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.05326560 |
82 | ABC transporters_Homo sapiens_hsa02010 | 1.05187522 |
83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03357880 |
84 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02612485 |
85 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.02512386 |
86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.01199117 |
87 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99252664 |
88 | Hepatitis C_Homo sapiens_hsa05160 | 0.98581173 |
89 | Measles_Homo sapiens_hsa05162 | 0.96375644 |
90 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.95828789 |
91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.94700948 |
92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91819201 |
93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.91043384 |
94 | Lysine degradation_Homo sapiens_hsa00310 | 0.90778416 |
95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.88547403 |
96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87390033 |
97 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87191572 |
98 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.86869858 |
99 | Shigellosis_Homo sapiens_hsa05131 | 0.85020740 |
100 | Apoptosis_Homo sapiens_hsa04210 | 0.84246768 |
101 | Platelet activation_Homo sapiens_hsa04611 | 0.84078771 |
102 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78940613 |
103 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77495303 |
104 | Bladder cancer_Homo sapiens_hsa05219 | 0.77176506 |
105 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75065175 |
106 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.71908584 |
107 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.71679465 |
108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71544361 |
109 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.71080156 |
110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69518963 |
111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68176128 |
112 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67997762 |
113 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.67553154 |
114 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66016071 |
115 | Hepatitis B_Homo sapiens_hsa05161 | 0.65183259 |
116 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.63933238 |
117 | Insulin resistance_Homo sapiens_hsa04931 | 0.63265580 |
118 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.63240526 |
119 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63020040 |
120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62428196 |
121 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.61986313 |
122 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.61716805 |
123 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61704141 |
124 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.58875888 |
125 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57693993 |
126 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57358798 |
127 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.55714912 |
128 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54680324 |
129 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53410844 |
130 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52430868 |
131 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51539674 |
132 | Mineral absorption_Homo sapiens_hsa04978 | 0.50557162 |
133 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.49876717 |
134 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49044478 |
135 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48769107 |
136 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.48346721 |
137 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47663869 |
138 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45879738 |
139 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.45326983 |
140 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44958094 |
141 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.42329825 |
142 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41877821 |
143 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.41255309 |
144 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.41075565 |
145 | Parkinsons disease_Homo sapiens_hsa05012 | 0.40283320 |
146 | Endocytosis_Homo sapiens_hsa04144 | 0.39879150 |
147 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37180842 |
148 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33246803 |
149 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.32629994 |
150 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32097985 |
151 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30705580 |
152 | Alzheimers disease_Homo sapiens_hsa05010 | 0.26980975 |
153 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26432849 |
154 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.19435465 |
155 | Prion diseases_Homo sapiens_hsa05020 | 0.18874689 |
156 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.17704937 |
157 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16297047 |
158 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.14508337 |
159 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.08838821 |
160 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.04692085 |
161 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.04545663 |
162 | Huntingtons disease_Homo sapiens_hsa05016 | 0.01472654 |
163 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1415975 |
164 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1214477 |
165 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.1198835 |
166 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | -0.1104449 |
167 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0914352 |
168 | Amoebiasis_Homo sapiens_hsa05146 | -0.0752604 |
169 | Viral myocarditis_Homo sapiens_hsa05416 | -0.0563542 |
170 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0538208 |
171 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0415080 |
172 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0172343 |